Page last updated: 2024-09-05

sch 58261 and cgs 15943

sch 58261 has been researched along with cgs 15943 in 8 studies

Compound Research Comparison

Studies
(sch 58261)
Trials
(sch 58261)
Recent Studies (post-2010)
(sch 58261)
Studies
(cgs 15943)
Trials
(cgs 15943)
Recent Studies (post-2010) (cgs 15943)
46014139028

Protein Interaction Comparison

ProteinTaxonomysch 58261 (IC50)cgs 15943 (IC50)
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoformHomo sapiens (human)0.97
Adenosine receptor A3Homo sapiens (human)0.406
Adenosine receptor A1Rattus norvegicus (Norway rat)0.006
Adenosine receptor A3Rattus norvegicus (Norway rat)0.0607
Adenosine receptor A2aHomo sapiens (human)0.012
Adenosine receptor A2bHomo sapiens (human)0.6304
Adenosine receptor A2bRattus norvegicus (Norway rat)0.0028
Adenosine receptor A2aRattus norvegicus (Norway rat)0.0029
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)1.28
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoformHomo sapiens (human)8.48
Casein kinase I isoform alphaHomo sapiens (human)0.82
Casein kinase I isoform deltaHomo sapiens (human)0.24
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform Homo sapiens (human)0.11
Casein kinase I isoform epsilonHomo sapiens (human)0.49
DNA-dependent protein kinase catalytic subunitHomo sapiens (human)0.14

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's1 (12.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daly, JW; Jacobson, KA; Melman, N; Padgett, WL; Shi, D; Siddiqi, SM; van Rhee, AM1
Baraldi, PG; Cacciari, B; Dionisotti, S; Ongini, E; Pineda de las Infantas y Villatoro, MJ; Spalluto, G; Zocchi, C1
Arslan, G; Dionisotti, S; Fredholm, BB; Kull, B; Ongini, E; Zocchi, C1
Baraldi, PG; Bergonzoni, M; Borea, PA; Cacciari, B; Dionisotti, S; Ongini, E; Spalluto, G; Varani, K1
Dionisotti, S; Fredholm, BB; Gessi, S; Irenius, E; Ongini, E1
Beukers, MW; Brussee, J; de Graaf, O; de Vries, H; Göblyös, A; Ijzerman, AP; Link, R; Mantri, M; Mulder-Krieger, T; van Veldhoven, J; von Frijtag Drabbe Künzel, JK1
Federico, S; Jacobson, KA; Jayasekara, PS; Kozma, E; Moro, S; Paoletta, S; Spalluto, G; Squarcialupi, L1
de Lera Ruiz, M; Lim, YH; Zheng, J1

Reviews

2 review(s) available for sch 58261 and cgs 15943

ArticleYear
Fluorescent ligands for adenosine receptors.
    Bioorganic & medicinal chemistry letters, 2013, Jan-01, Volume: 23, Issue:1

    Topics: Boron Compounds; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Ligands; Protein Binding; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1

2013
Adenosine A2A receptor as a drug discovery target.
    Journal of medicinal chemistry, 2014, May-08, Volume: 57, Issue:9

    Topics: Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Crystallography, X-Ray; Drug Discovery; Humans; Ligands; Protein Conformation; Receptor, Adenosine A2A; Signal Transduction

2014

Other Studies

6 other study(ies) available for sch 58261 and cgs 15943

ArticleYear
Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists.
    Journal of medicinal chemistry, 1996, Jan-19, Volume: 39, Issue:2

    Topics: Animals; Binding Sites; Humans; Male; Mice; Models, Molecular; Motor Activity; Purinergic P1 Receptor Antagonists; Rats; Structure-Activity Relationship; Thiophenes

1996
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: potent and selective A(2A) adenosine antagonists.
    Journal of medicinal chemistry, 1996, Mar-01, Volume: 39, Issue:5

    Topics: Animals; Binding, Competitive; Brain; Male; Molecular Structure; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Antagonists; Pyrimidines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Structure-Activity Relationship; Triazoles

1996
Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    British journal of pharmacology, 1997, Volume: 121, Issue:3

    Topics: Animals; Binding, Competitive; CHO Cells; Cricetinae; Cyclic AMP; Humans; Purinergic P1 Receptor Antagonists; Pyrimidines; Radioligand Assay; Rats; Receptor, Adenosine A2A; Receptors, Purinergic P1; Species Specificity; Transfection; Triazoles

1997
Design, synthesis, and biological evaluation of a second generation of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as potent and selective A2A adenosine receptor antagonists.
    Journal of medicinal chemistry, 1998, Jun-04, Volume: 41, Issue:12

    Topics: Adenosine; Animals; Binding, Competitive; Blood Platelets; CHO Cells; Corpus Striatum; Cricetinae; Cyclic AMP; Drug Design; Humans; Male; Mice; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship; Thermodynamics; Tumor Cells, Cultured

1998
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 1999, Volume: 359, Issue:1

    Topics: Animals; Cell Line; CHO Cells; Cricetinae; Cyclic AMP; Humans; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinazolines; Rats; Transfection; Triazines; Triazoles; Xanthines

1999
2-Amino-6-furan-2-yl-4-substituted nicotinonitriles as A2A adenosine receptor antagonists.
    Journal of medicinal chemistry, 2008, Aug-14, Volume: 51, Issue:15

    Topics: Adenosine A2 Receptor Antagonists; Amines; Animals; Cell Line; Cricetinae; Cyclic AMP; Furans; Humans; Models, Molecular; Molecular Structure; Nicotinic Acids; Nitriles; Receptor, Adenosine A2A; Structure-Activity Relationship

2008
chemdatabank.com